Picolinic acid → HCID 67619906, compound

HRID 2293370Notes

Reaction equation

HRID 2293370 reaction equation
[NH:1]1[CH2:8][CH2:7][CH2:6][C@H:2]1[C:3]([OH:5])=O.[CH2:9]([NH:16][C:17](=[O:24])[C@H:18]([C@H:20]([CH2:22][CH3:23])[CH3:21])[NH2:19])[C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1.[CH2:25](N(CC)CC)C.[N:32]1[CH:37]=[CH:36][CH:35]=[CH:34][C:33]=1[C:38]([OH:40])=O>C1COCC1>[N:32]1[CH:37]=[CH:36][CH:35]=[CH:34][C:33]=1[C:38](=[O:40])[CH2:25][N:1]1[CH2:8][CH2:7][CH2:6][C@H:2]1[C:3]([N:16]([CH2:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1)[C:17](=[O:24])[C@H:18]([C@H:20]([CH2:22][CH3:23])[CH3:21])[NH2:19])=[O:5]

Participants

5

Reactant 3

HCID 1018Picolinic acidHCID 8471TriethylamineHCID 86751513HCID 86751513, compound

Product 1

HCID 67619906HCID 67619906, compoundYield 10%

Reagents, catalysts & solvents 1

HCID 8028TetrahydrofuranSolvent

Procedure

Using the procedure described in Example 5, a solution of L-proline-L-isoleucine benzylamide (148 mg, 0.47 mmol), and triethylamine (0.13 mL, 0.93 mmol, 2.0 eq) in THF (10 mL), was treated with 234 mg (1.50 mmol) of 2-(alpha-chloroacyl)pyridine (prepared from picolinic acid, using the procedure described in example 1) to provide 20 mg, (10%) of L-isoleucine, N-[1-(2-pyrid-2-yl-2-oxoethyl)-L-prolyl] benzylamide.

Sources & evidence

ORD record
ord-a6d6f5e081c54826bc7be5832787f4da
Source dataset
uspto-grants-1997_11
Patent number
US05686424

Reaction notes

Loading…